688739

Liaoning Chengda Biotechnology
688739

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥10.87B
EV
CN¥5.48B
Shares Outstanding
411.64M
Beta
0.69

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN¥33.00
P/E 2025E
27.50x
P/Revenue 2025E
5.96x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Liaoning Chengda Biotechnology Co.,Ltd.

gainify
688739

Liaoning Chengda Biotechnology Co.,Ltd.

688739

Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines. Th...

Sector

Industry

CEO

Mao, Yu

Employees

1,807

IPO Date

Headquarters

No. 1 Xinfang Street, Hunnan New District, Shenyang, Liaoning Province, 110179, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.